Betacetylmethadol

Betacetylmethadol
Clinical data
ATC code
  • None
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • CA: Schedule I
  • DE: Anlage I (Authorized scientific use only)
  • US: Schedule I
Identifiers
IUPAC name
  • (3S,6R)-6-(dimethylamino)-4,4-diphenyl-3-heptanyl acetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H31NO2
Molar mass353.506 g·mol−1
3D model (JSmol)
SMILES
  • O=C(O[C@H](C(c1ccccc1)(c2ccccc2)C[C@H](N(C)C)C)CC)C
InChI
  • InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22+/m1/s1
  • Key:XBMIVRRWGCYBTQ-GCJKJVERSA-N

Betacetylmethadol is a synthetic opioid.[1] It is a diastereoisomer of alphacetylmethadol (as well as levacetylmethadol).[1] In the United States, betacetylmethadol is a Schedule I drug Narcotic under the Controlled Substances Act, with an ACSCN of 9607 and a 2 gramme manufacturing quota as of 2014.[2]

See also

References

  1. 1 2 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology. 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424. S2CID 19815273.
  2. ↑ 21 U.S.C. § 812(b)(1)


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.